440 related articles for article (PubMed ID: 27993408)
1. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
[TBL] [Abstract][Full Text] [Related]
2. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
3. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
Renoux C; Coulombe J; Suissa S
BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
[TBL] [Abstract][Full Text] [Related]
5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
6. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
7. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
[TBL] [Abstract][Full Text] [Related]
8. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma C; Zint K; Elsaesser A; Bartels DB; Lip GY;
Am J Med; 2015 Dec; 128(12):1306-13.e1. PubMed ID: 26239094
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study.
Dogan V; Başaran Ö; Beton O; Tekinalp M; Bolat I; Kalaycioğlu E; Aykan AÇ; Taşar O; Şafak Ö; Kalçik M; Yaman M; Kirma C; Biteker M
Coron Artery Dis; 2016 Sep; 27(6):497-503. PubMed ID: 27182772
[TBL] [Abstract][Full Text] [Related]
11. Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.
Gullón A; Formiga F; Díez-Manglano J; Mostaza JM; Cepeda JM; Pose A; Castiella J; Suárez-Fernández C;
Intern Emerg Med; 2019 Jan; 14(1):59-69. PubMed ID: 30191535
[TBL] [Abstract][Full Text] [Related]
12. [Patients' characteristics and clinical management of atrial fibrillation in primary healthcare in Spain: FIATE Study].
Lobos-Bejarano JM; del Castillo-Rodríguez JC; Mena-González A; Alemán-Sánchez JJ; Cabrera de León A; Barón-Esquivias G; Pastor-Fuentes A;
Med Clin (Barc); 2013 Oct; 141(7):279-86. PubMed ID: 23683967
[TBL] [Abstract][Full Text] [Related]
13. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
Bajorek B; Magin PJ; Hilmer S; Krass I
J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
[TBL] [Abstract][Full Text] [Related]
15. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.
Fauchier L; Greenlaw N; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Steg PG;
PLoS One; 2015; 10(4):e0125164. PubMed ID: 25915904
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation.
Díez-Manglano J; Mostaza JM; Pose A; Formiga F; Cepeda JM; Gullón A; Camafort M; Castiella J; Rovira E; Jarauta E; Suárez C
Geriatr Gerontol Int; 2018 Aug; 18(8):1219-1224. PubMed ID: 29897154
[TBL] [Abstract][Full Text] [Related]
17. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
Mizokami Y; Yamamoto T; Atarashi H; Yamashita T; Akao M; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
PLoS One; 2020; 15(11):e0240859. PubMed ID: 33151969
[TBL] [Abstract][Full Text] [Related]
18. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
Wolff A; Shantsila E; Lip GY; Lane DA
Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
[TBL] [Abstract][Full Text] [Related]
19. The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation.
Moulson N; McIntyre WF; Oqab Z; Yazdan-Ashoori P; Quinn KL; van Oosten E; Hopman WM; Baranchuk A
Postgrad Med J; 2017 Jun; 93(1100):308-312. PubMed ID: 27307471
[TBL] [Abstract][Full Text] [Related]
20. [Fine-tuning of antithrombotic therapy in patients with non-valvular atrial fibrillation. The AFINVA register].
Dubois Marques D; Mora Llabata V; Pacheco Arroyo J; Gasull Insertis S; Vicente Cañizares M; Roldán Torres I;
Aten Primaria; 2018; 50(6):340-349. PubMed ID: 28867157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
